1 | 0.12% saline | - | - | - | - | 1件: 299 299 |
2 | 0.9% Isotonic Saline (IS) | - | - | - | - | 1件: 299 299 |
3 | 0.9% Isotonic Saline (IS), 4mL | - | - | - | - | 1件: 299 299 |
4 | 0.9% normal saline (control) | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
5 | 0.9% w/v sodium chloride solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
6 | 033841 | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
7 | 1,5 (Butylimino)-1,5-dideoxy-D-glucitol | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 299 299 |
8 | 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
9 | 100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
10 | 100 mg ELX /50 mg TEZ /75 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
11 | 100 mg ELX/50 mg TEZ /75 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
12 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
13 | 100 mg TEZ/150 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
14 | 100 mg VX-445 /50 mg TEZ/75 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
15 | 100 mg VX-445/50 mg TEZ /75 mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
16 | 100 mg/m2 dose | - | - | - | - | 1件: 299 299 |
17 | 100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
18 | 100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
19 | 100-mg ELX / 50-mg TEZ / 75 -mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
20 | 100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
21 | 100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
22 | 100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
23 | 100-mg VX-445 /50-mg TEZ/75-mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
24 | 100-mg VX-445/50-mg TEZ/75-mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
25 | 100g ELX / 50mg TEZ / 75mg IVA | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
26 | 100mg ELX/50mg TEZ /75mg IVA | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
27 | 100mg VX-445/50mg TEZ /75mg IVA FDC | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
28 | 129Xe Small and Large Human Lung Coil | - | - | - | - | 1件: 299 299 |
29 | 13^C Spirulina Platensis Gastric Emptying Breath Test (GEBT) | 1件: Spirulina platensis Spirulina platensis | - | - | - | 1件: 299 299 |
30 | 150-mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
31 | 150mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
32 | 2% Chlorhexidine solution wipes | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 1件: 299 299 |
33 | 2,3-dihydroxybutanedioic acid | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 299 299 |
34 | 2-aminoethanethiol | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 2件: 19 19, 299 |
35 | 200 mg/m2 dose | - | - | - | - | 1件: 299 299 |
36 | 25-Hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
37 | 2622U90 Duramycin | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
38 | 291844 | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 2件: 246 246, 299 |
39 | 3He Human Lung Coil | - | - | - | - | 1件: 299 299 |
40 | 4% chlorhexidine gluconate liquid skin cleanser | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
41 | 4-phenylbutyrate | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 2件: 251 251, 299 |
42 | 4.2% NaCl/Inhalation solution | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
43 | 4D-710 | - | - | - | - | 1件: 299 299 |
44 | 5-methyltetrahydrofolate and vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 1件: 299 299 |
45 | 50 mg ELX/25 mg TEZ/37.5 mg IVA | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
46 | 50 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
47 | 5000 IU of cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
48 | 552-02 | - | - | - | - | 2件: 53 53, 299 |
49 | 6% Hypertonic Saline (HS), 4mL | - | - | - | - | 1件: 299 299 |
50 | 7% Hypertonic Saline (HS) | - | - | - | - | 1件: 299 299 |
51 | 7% NaCl | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
52 | 7% saline | - | - | - | - | 1件: 299 299 |
53 | 75-mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
54 | 80mg ELX / 40mg TEZ / 60mg IVA | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
55 | [ELX/TEZ/IVA] | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
56 | [INS1007] | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
57 | [JBT-101] | - | - | - | - | 3件: 50 50, 51, 299 |
58 | [MEDI-563] | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
59 | [N/A] | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 10件: 11 11, 13, 19, 46, 51, 61, 65, 78, 97, 299 |
60 | [NA] | 1件: Vedolizumab Vedolizumab | 1件: D08083
D08083
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 25件: 3 3, 6, 11, 13, 14, 28, 35, 41, 46, 49, 50, 53, 62, 63, 65, 75, 79, 96, 97, 98, 222, 229, 288, 294, 299 |
61 | [Salbutamol] | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
62 | [SPX-101] | - | - | - | - | 1件: 299 299 |
63 | [Ta1] | 1件: Thymalfasin Thymalfasin | 1件: D06116
D06116
| - | - | 1件: 299 299 |
64 | [Ventolin] | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
65 | [VX-121/TEZ/D-IVA] | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
66 | [VX-445/TEZ/IVA] | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
67 | [VX-661 / VX-770] | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
68 | [VX-770] | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
69 | A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP) | - | - | - | - | 1件: 299 299 |
70 | AAC Hexal | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
71 | ABBV-119 | 1件: Galicaftor Galicaftor | 1件: D11724
D11724
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
72 | ABBV-2222 | - | - | - | - | 1件: 299 299 |
73 | ABBV-3067 | - | - | - | - | 1件: 299 299 |
74 | ABELCET | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
75 | ACC | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
76 | ACC600Tabs | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
77 | Acebilustat | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 |
78 | Acetate | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
79 | Acetylcysteine | 1件: Pirfenidone Pirfenidone | 1件: D01583
D01583
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
80 | ACETYLCYSTEINE SODIUM | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
81 | ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable | 1件: Tranexamic acid Tranexamic acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 299 299 |
82 | Activated smart device | - | - | - | - | 1件: 299 299 |
83 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | 1件: 299 299 |
84 | Actrapid 100 IU/ml, Solution for injection in a vial | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
85 | Actrapid Penfill 100UI/ml | - | - | - | - | 1件: 299 299 |
86 | Acute Antioxidant | - | - | - | - | 1件: 299 299 |
87 | Ad26.COV2-S.02 | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
88 | Adempas | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 86, 88, 225, 299 |
89 | Adempas 0.125 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
90 | Adempas 0.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
91 | Adempas 1.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
92 | Adempas 2.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
93 | Adeno-associated virus-CFTR vector | - | - | - | - | 1件: 299 299 |
94 | Adrenalina | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
95 | Advagraf prolonged-release hard capsules | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
96 | AER002 | - | - | - | - | 1件: 299 299 |
97 | Aeroquin | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
98 | Aerosolized, human, plasma-derived Alpha-1 Antitrypsin | - | - | - | - | 1件: 299 299 |
99 | Aerosoltherapy | - | - | - | - | 1件: 299 299 |
100 | AeroVanc | 1件: Vancomycin Vancomycin | 2件: D00212
D00212
,
D00926
| - | - | 1件: 299 299 |
101 | Air | 1件: Pirfenidone Pirfenidone | 1件: D01583
D01583
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 3 3, 13, 51, 58, 85, 97, 193, 299 |
102 | AIR DNase | - | - | - | - | 1件: 299 299 |
103 | AIR DNase™ | - | - | - | - | 1件: 299 299 |
104 | Airway clearance technique | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
105 | Ajulemic acid | 1件: Ajulemic acid Ajulemic acid | 1件: D11312
D11312
| 1件: CNR2 CNR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 50 50, 51, 299 |
106 | Alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 5件: 6 6, 13, 251, 298, 299 |
107 | Albuterol | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 12 12, 13, 86, 89, 113, 231, 256, 299 |
108 | Albuterol inhaler. | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 231 231, 299 |
109 | Alendronate | 1件: Alendronic acid Alendronic acid | 2件: D00939
D00939
,
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 7件: 19 19, 41, 46, 50, 271, 274, 299 |
110 | Alendronate sodium | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 19 19, 299 |
111 | Alginate | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 2件: 53 53, 299 |
112 | Alginate oligosaccharide | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
113 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 |
114 | Alpha-1 HC 100 mg | - | - | - | - | 1件: 299 299 |
115 | Alpha-1 HC 200 mg | - | - | - | - | 1件: 299 299 |
116 | Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
117 | Alpha1-Proteinase Inhibitor (Human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
118 | ALTU-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 |
119 | ALTUS-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 |
120 | ALX-009 | - | - | - | - | 1件: 299 299 |
121 | AMIKACIN | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 2件: 60 60, 299 |
122 | Amikacin nebulization | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
123 | AMIKACIN SULFATE | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
124 | Amikacina | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
125 | Amikacina liposomal (Arikace?) | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
126 | Amikacine | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
127 | Amikacine nebulization | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
128 | Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
129 | Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
130 | AMILASA | - | - | - | - | 1件: 299 299 |
131 | Amiloride | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 4件: 13 13, 67, 225, 299 |
132 | Amiloride HCl | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
133 | Amiloride Solution for Inhalation | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
134 | Amitriptylin | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
135 | Amitriptylin-CT | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
136 | Amitriptylin-ct Tabletten | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
137 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 2件: D00809
D00809
,
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 78 78, 97, 226, 299 |
138 | Amoxicillin | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 7件: 6 6, 46, 63, 96, 97, 222, 299 |
139 | Amoxicillin and Clavulanic acid | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
140 | Amphotericin | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
141 | Amphotericin B | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
142 | AMYLASE | - | - | - | - | 1件: 299 299 |
143 | Anakinra | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
144 | Andecaliximab | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 4件: 46 46, 96, 97, 299 |
145 | Anti-pseudomonas IgY gargle | - | - | - | - | 1件: 299 299 |
146 | Anti-reflux pharmacotherapy | - | - | - | - | 1件: 299 299 |
147 | Antibiotic | - | - | - | - | 1件: 299 299 |
148 | Antioxidant Cocktail | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 299 299 |
149 | Antistaminici H1 - H2 | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
150 | AP | 1件: Ampicillin Ampicillin | 3件: D00204
D00204
,
D01251
,
D02119
| - | - | 4件: 2 2, 6, 13, 299 |
151 | AP-PA02 | 1件: Ampicillin Ampicillin | 3件: D00204
D00204
,
D01251
,
D02119
| - | - | 1件: 299 299 |
152 | API | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
153 | AquADEK | - | - | - | - | 1件: 299 299 |
154 | AquADEKs-2 | - | - | - | - | 1件: 299 299 |
155 | ARD-3150 | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
156 | Arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 11件: 46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 |
157 | Aridol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
158 | Aridol or Osmohale | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
159 | ARIKACE™ | - | - | - | - | 1件: 299 299 |
160 | Arikayce | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
161 | Arikayce™ | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
162 | Arikayce™ 140 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
163 | Arikayce™ 560 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
164 | Arikayce™ 70 mg | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
165 | ARO-ENaC | - | - | - | - | 1件: 299 299 |
166 | ATALUREN | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 6件: 19 19, 113, 140, 246, 299, 329 |
167 | Ataluren (PTC124®) | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 299 299 |
168 | Atorvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 18件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
169 | Atropina | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
170 | Augmentin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
171 | Aurexis | 1件: Tefibazumab Tefibazumab | 1件: D06054
D06054
| - | - | 1件: 299 299 |
172 | Aurexis® (tefibazumab) | 1件: Tefibazumab Tefibazumab | 1件: D06054
D06054
| - | - | 1件: 299 299 |
173 | Avian polyclonal IgY antibody against PA | - | - | - | - | 1件: 299 299 |
174 | Avibactam | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
175 | AZD1236 | 1件: AZD-1236 AZD-1236 | - | - | - | 1件: 299 299 |
176 | AZD5634 | - | - | - | - | 1件: 299 299 |
177 | AZD5634 for infusion | - | - | - | - | 1件: 299 299 |
178 | AZD5634 for inhalation | - | - | - | - | 1件: 299 299 |
179 | AZD7986 | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 2件: 44 44, 299 |
180 | AZD9668 | - | - | - | - | 1件: 299 299 |
181 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 |
182 | Azithromycin 250 mg tablets | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
183 | Azithromycin 500 mg film-coated tablet | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
184 | AZITHROMYCIN DIHYDRATE | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 2件: 228 228, 299 |
185 | AZLI | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
186 | AZLI 75 mg three times a day (TID) | - | - | - | - | 1件: 299 299 |
187 | AZLI 75 mg three times daily (TID) | - | - | - | - | 1件: 299 299 |
188 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | 1件: 299 299 |
189 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | 1件: 299 299 |
190 | Aztreonam | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 2件: 228 228, 299 |
191 | Aztreonam for Inhalation (AI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
192 | Aztreonam for Inhalation Solution | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
193 | Aztreonam for Inhalation Solution (AZLI) | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
194 | AZTREONAM LYSINE | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
195 | Aztreonam Lysine for Inhalation | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
196 | Aztreonam solución para inhalación | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
197 | Aztreonan lysine | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
198 | Bactrim | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
199 | BAL | 1件: Dimercaprol Dimercaprol | 1件: D00167
D00167
| - | - | 5件: 49 49, 51, 84, 85, 299 |
200 | Balance | 1件: Olive oil Olive oil | 1件: D03311
D03311
| - | - | 8件: 6 6, 11, 13, 81, 113, 122, 149, 299 |
201 | BAY 85-8501 | - | - | - | - | 1件: 299 299 |
202 | BAY q 3939 | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
203 | BAY63-2521 | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 86, 299 |
204 | BAY85-8501 | - | - | - | - | 1件: 299 299 |
205 | BAYQ3939 | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
206 | BCG | 1件: BCG vaccine BCG vaccine | 1件: D03063
D03063
| - | - | 1件: 299 299 |
207 | BCG TICE Vaccine | 1件: BCG vaccine BCG vaccine | 1件: D03063
D03063
| - | - | 1件: 299 299 |
208 | Behavioral: Aerobic exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 299 299 |
209 | Behavioral: Balance exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 299 299 |
210 | Behavioral: Environmental Decontamination | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 1件: 299 299 |
211 | Behavioral: Exercise | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 3件: 6 6, 265, 299 |
212 | Behavioral: Flexibility and postural exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 299 299 |
213 | Behavioral: Resistance exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 299 299 |
214 | Behavioral: Tobacco Treatment Specialist (TTS) intervention | 1件: Tobacco leaf Tobacco leaf | - | - | - | 1件: 299 299 |
215 | Behavioral: Unsupervised exercise | - | - | - | - | 1件: 299 299 |
216 | Benralizumab | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
217 | Beta-Adrenergic cocktail | 1件: Pilocarpine Pilocarpine | 3件: D00525
D00525
,
D02200
,
D05478
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
218 | Bethkis | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
219 | BH4 | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 5件: 51 51, 86, 124, 240, 299 |
220 | BH4 20mg | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 299 299 |
221 | BH4 5mg | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 299 299 |
222 | BI 1265162 | - | - | - | - | 1件: 299 299 |
223 | BI 1265162 10 µg | - | - | - | - | 1件: 299 299 |
224 | BI 1265162 100 µg | - | - | - | - | 1件: 299 299 |
225 | BI 1265162 25 µg | - | - | - | - | 1件: 299 299 |
226 | BI 1265162 50 µg | - | - | - | - | 1件: 299 299 |
227 | BI 1323495 | - | - | - | - | 1件: 299 299 |
228 | BI 443651 | - | - | - | - | 1件: 299 299 |
229 | Biaxin ( clarithromycin) | 1件: Clarithromycin Clarithromycin | 1件: D00276
D00276
| - | - | 1件: 299 299 |
230 | BIIL 283 BS (Amelubent) | - | - | - | - | 1件: 299 299 |
231 | BIIL 284 BS, high dose | - | - | - | - | 1件: 299 299 |
232 | BIIL 284 BS, high dose, adult patients | - | - | - | - | 1件: 299 299 |
233 | BIIL 284 BS, high dose, pediatric patients | - | - | - | - | 1件: 299 299 |
234 | BIIL 284 BS, low dose | - | - | - | - | 1件: 299 299 |
235 | BIIL 284 BS, low dose, adult patients | - | - | - | - | 1件: 299 299 |
236 | BIIL 284 BS, low dose, pediatric patients | - | - | - | - | 1件: 299 299 |
237 | BIIL 284 BS, medium dose, adult patients | - | - | - | - | 1件: 299 299 |
238 | BIIL 284 BS, medium dose, pediatric patients | - | - | - | - | 1件: 299 299 |
239 | Biklin | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
240 | Bio-25 probiotic | - | - | - | - | 1件: 299 299 |
241 | Bisphosphonate treatment | - | - | - | - | 2件: 113 113, 299 |
242 | BLF | - | - | - | - | 1件: 299 299 |
243 | Blood draw | 1件: Lorazepam Lorazepam | 1件: D00365
D00365
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 19, 65, 231, 299 |
244 | Blood draw. | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 231 231, 299 |
245 | Blood sample | - | - | - | - | 18件: 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
246 | Blood sampling for determination of serum Zn | 1件: Zinc Zinc | - | - | - | 1件: 299 299 |
247 | Blood test | - | - | - | - | 6件: 36 36, 51, 86, 113, 162, 299 |
248 | Boost VHC | - | - | - | - | 1件: 299 299 |
249 | Boots High Strength Garlic Odour Controlled | 1件: Garlic Garlic | 1件: D12020
D12020
| - | - | 1件: 299 299 |
250 | BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
251 | Bramitob | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
252 | BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
253 | Bramitob 300mg/4ml Nebuliser Solution | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
254 | BRAMITOB*NEBUL 28F 300MG/4ML | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
255 | BRAMITOB*NEBUL 56F 300MG/4ML | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
256 | Bramitob® administered by PARI eFlow® rapid electronic nebulizer | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
257 | Bramitob® administered by PARI LC® PLUS nebulizer | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
258 | Brensocatib | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
259 | Brensocatib 10 mg | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
260 | Brensocatib 25 mg | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
261 | Broccoli | 1件: Broccoli Broccoli | - | - | - | 3件: 36 36, 97, 299 |
262 | Broccoli sprouts | 1件: Broccoli Broccoli | - | - | - | 1件: 299 299 |
263 | Bronchial mucus collection | - | - | - | - | 1件: 299 299 |
264 | Bronchitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
265 | Bronchoscopy with BAL | 1件: Dimercaprol Dimercaprol | 1件: D00167
D00167
| - | - | 1件: 299 299 |
266 | Bucelipase alfa | 1件: Esomeprazole Esomeprazole | 4件: D01984
D01984
,
D04056
,
D07917
,
D09339
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 299 299 |
267 | BUDESONIDE | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
268 | Budesonide-formoterol single inhaler | 1件: Formoterol Formoterol | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
269 | Burlulipase | 1件: Burlulipase Burlulipase | - | - | - | 1件: 299 299 |
270 | BX004-A | - | - | - | - | 1件: 299 299 |
271 | C01CA04 - Dopamina | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
272 | Calcium | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 30件: 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
273 | Calcium carbonate | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 13 13, 19, 46, 53, 75, 96, 235, 299 |
274 | Calfactant | 1件: Calfactant Calfactant | 1件: D03317
D03317
| - | - | 1件: 299 299 |
275 | Carbonate | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
276 | Cavosonstat | 1件: Cavosonstat Cavosonstat | 1件: D10916
D10916
| - | - | 1件: 299 299 |
277 | Cayston | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
278 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
279 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
280 | CB-280 | - | - | - | - | 1件: 299 299 |
281 | CEFALEXIN | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
282 | Cefepime | 1件: Trimethoprim Trimethoprim | 2件: D00145
D00145
,
D06236
| - | - | 2件: 60 60, 299 |
283 | Ceftaroline | 1件: Ceftaroline fosamil Ceftaroline fosamil | 1件: D08884
D08884
| - | - | 1件: 299 299 |
284 | Ceftazidim | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
285 | Ceftazidim Fresenius Kabi | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
286 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
287 | Ceftazidima | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
288 | CEFTAZIDIMA PENTAIDRATO | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
289 | CEFTAZIDIME | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
290 | Ceftazidime and tobramycin | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
291 | CEFTAZIDIME PENTAHYDRATE | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
292 | Ceftazidime/avibactam | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
293 | Ceftolozane | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
294 | Ceftolozane/Tazobactam | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
295 | Cefuroxim | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
296 | Cefuroxime | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 2件: 97 97, 299 |
297 | Cephalexin | 1件: Cephalexin Cephalexin | 2件: D00263
D00263
,
D00906
| - | - | 1件: 299 299 |
298 | CF patients with a G551D mutation and treated with Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
299 | CFTR Modulators | - | - | - | - | 1件: 299 299 |
300 | CFTR potentiator | - | - | - | - | 1件: 299 299 |
301 | ChAdOx1 nCoV-19 | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 3件: 46 46, 51, 299 |
302 | CHF 6333 | - | - | - | - | 1件: 299 299 |
303 | CHF6333 (Part 1 - SAD) | - | - | - | - | 1件: 299 299 |
304 | CHF6333 (Part 2 - MAD) | - | - | - | - | 1件: 299 299 |
305 | Chlorhexidine | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 2件: 86 86, 299 |
306 | Chlorhexidine Gluconate | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 1件: 299 299 |
307 | Chlorhexidine gluconate oral rinse | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 1件: 299 299 |
308 | Chloride | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 29件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
309 | CHOLECALCIFEROL | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 10件: 13 13, 19, 34, 46, 49, 75, 96, 97, 298, 299 |
310 | Cholecalciferol (Vitamin D3) | 1件: Interferon beta-1a Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 299 |
311 | Cholecalciferol (vitaminD3) | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
312 | Cholecalciferol Pill | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
313 | Choline | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 4件: 93 93, 171, 193, 299 |
314 | Choline Chloride | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 1件: 299 299 |
315 | Choline supplementation | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 1件: 299 299 |
316 | Chronic Antioxidant | - | - | - | - | 1件: 299 299 |
317 | Cipro (Ciprofloxacin, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
318 | Cipro Inhale | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
319 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 5件: 2 2, 60, 96, 97, 299 |
320 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
321 | Ciprofloxacin (Cipro Inhale, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
322 | Ciprofloxacin (Cipro, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
323 | Ciprofloxacin (ciproxin) | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
324 | Ciprofloxacin dispersion for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
325 | Ciprofloxacin DPI | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
326 | Ciprofloxacin DPI (BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
327 | Ciprofloxacin for Inhalation | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
328 | Ciprofloxacin hydrochloride | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 2件: 96 96, 299 |
329 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
330 | Ciprofloxacin Inhale | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
331 | Ciprofloxacina | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
332 | CIPROFLOXACINA CLORIDRATO | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
333 | Ciproxin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
334 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
335 | Ciproxin Suspension | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
336 | CIPROXIN*6CPR RIV 500MG | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
337 | Clarithromycin | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
338 | Claritromycin | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
339 | Claritromycin 500mg film coated tablets | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
340 | Clavulanate | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 299 299 |
341 | CLAVULANIC ACID | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
342 | Clindamycin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 2件: 46 46, 299 |
343 | CLORURO SODICO 7% | - | - | - | - | 1件: 299 299 |
344 | Cobamamide | 1件: Cobamamide Cobamamide | 1件: D00042
D00042
| - | - | 1件: 299 299 |
345 | Colimicina | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
346 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
347 | Colimycine | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
348 | COLIMYCINE inhalation | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
349 | COLIMYCINE injectable | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
350 | COLISTIMETATO SODICO | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
351 | Colistimethat-Natrium | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
352 | COLISTIMETHATE | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
353 | Colistimethate 75 mg inhaled two times daily | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
354 | COLISTIMETHATE SODIUM | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
355 | COLISTIMETHATE SODIUM (A COMPONENT) | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
356 | Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
357 | Colistimethate sodium (promixin) | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
358 | COLISTIN | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
359 | Colistin CF | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
360 | Colistin Forest - Trockenstechampullen mit Lösungsmittel | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
361 | COLISTIN MESILATE SODIUM | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
362 | Colistineb | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
363 | COLISTINEB 2MUI | 1件: Colistimethate Colistimethate | 1件: D02049
D02049
| - | - | 1件: 299 299 |
364 | Colobreathe | 1件: Colistin Colistin | 2件: D02138
D02138
,
D07746
| - | - | 1件: 299 299 |
365 | Colomycin | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
366 | Comirnaty | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 5件: 13 13, 46, 51, 53, 299 |
367 | Comirnaty concentrate for dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 2件: 53 53, 299 |
368 | Compound 1a | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 2件: 246 246, 299 |
369 | Continuous glucose monitor (CGM) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
370 | Continuous glucose monitoring | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 2件: 75 75, 299 |
371 | Continuous Glucose Monitoring System (CGMS) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
372 | Continuous infusion Cefepime | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
373 | Continuous infusion Ceftazidime | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
374 | Continuous infusion Meropenem | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
375 | Continuous infusion Piperacillin tazobactam | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
376 | Continuous infusion Ticarcillin-clavulanate | 1件: Piperacillin Piperacillin | 3件: D00466
D00466
,
D02251
,
D08380
| - | - | 1件: 299 299 |
377 | Control | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 6 6, 46, 168, 299 |
378 | Control Group 0.9% Isotonic Saline | - | - | - | - | 1件: 299 299 |
379 | Control multivitamin | - | - | - | - | 1件: 299 299 |
380 | COVID-19 mRNA vaccine (nucleoside-modified) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 4件: 13 13, 46, 51, 299 |
381 | COVID-19 mRNA vaccine Moderna (CX-024414) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 4件: 13 13, 46, 51, 299 |
382 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
383 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 3件: 46 46, 51, 299 |
384 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 3件: 46 46, 51, 299 |
385 | Covid-19 Vaccine Janssen | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 2件: 53 53, 299 |
386 | COVID-19 Vaccine Janssen suspension for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
387 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 2件: 53 53, 299 |
388 | COVID-19 Vaccine Moderna | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 4件: 46 46, 51, 65, 299 |
389 | COVID-19 Vaccine Moderna dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
390 | CPX | 1件: 8-cyclopentyl-1,3-dipropylxanthine 8-cyclopentyl-1,3-dipropylxanthine | - | - | - | 2件: 215 215, 299 |
391 | CR002 | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 299 299 |
392 | CR002 Liquid API | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 299 299 |
393 | CRC3357, ZK-355322, Leukoton | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 |
394 | CREON | - | - | - | - | 2件: 298 298, 299 |
395 | Creon 10.000, hårde enterokapsler | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
396 | Creon 10000 | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
397 | CREON 10000 Capsules | - | - | - | - | 1件: 299 299 |
398 | Creon 25.000, hårde enterokapsler | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
399 | Creon 25000 | - | - | - | - | 2件: 298 298, 299 |
400 | Creon 40.000, hårde enterokapsler | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
401 | CREON IR | - | - | - | - | 1件: 299 299 |
402 | Creon N | - | - | - | - | 1件: 299 299 |
403 | CREON N 25000 | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
404 | Creon® | - | - | - | - | 1件: 299 299 |
405 | Creon® (DR/GR) | - | - | - | - | 1件: 299 299 |
406 | Creon® 25,000 | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
407 | Crestor | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 49 49, 79, 299 |
408 | CSL787 | - | - | - | - | 1件: 299 299 |
409 | CTX-4430 | - | - | - | - | 1件: 299 299 |
410 | Curcuma Longa | 1件: Turmeric Turmeric | - | - | - | 2件: 96 96, 299 |
411 | Curcuma Longa Extract | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
412 | Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
413 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 11件: 2 2, 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 |
414 | CYC202 | 1件: Seliciclib Seliciclib | - | - | - | 1件: 299 299 |
415 | CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL] | - | - | - | - | 1件: 299 299 |
416 | CYSTAGON | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 3件: 8 8, 19, 299 |
417 | Cystagon (cysteamine bitartrate) immediate-release capsules | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 299 299 |
418 | Cysteamine | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 4件: 8 8, 19, 21, 299 |
419 | Cysteamine Bitartrate | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 4件: 8 8, 19, 21, 299 |
420 | Cysteamine bitartrate (Cystagon) | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 299 299 |
421 | Cystic Fibrosis Ready to Use Supplemental Food | - | - | - | - | 1件: 299 299 |
422 | D-a-tocopheryl PEG 1000 succinate | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 1件: 299 299 |
423 | D-glucitol | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 2件: 28 28, 299 |
424 | D-IVA | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
425 | D6-25-hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
426 | DCI | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 2件: 6 6, 299 |
427 | DCI 1020 | 1件: Dichloroisoproterenol Dichloroisoproterenol | - | - | - | 1件: 299 299 |
428 | De-activated smart device | - | - | - | - | 1件: 299 299 |
429 | Decolonization | - | - | - | - | 1件: 299 299 |
430 | Denosumab | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 7件: 46 46, 50, 93, 95, 96, 274, 299 |
431 | Denufosol | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
432 | Denufosol tetrasodium (INS37217) | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
433 | Denufosol Tetrasodium (INS37217) Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
434 | Denufosol tetrasodium Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
435 | DEPELESTAT | - | - | - | - | 1件: 299 299 |
436 | Desoxyribonuclease | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
437 | Detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
438 | Detoxifying agents for antineoplastic treatment | 1件: Cobamamide Cobamamide | 1件: D00042
D00042
| - | - | 2件: 299 299, 337 |
439 | Deuterated Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
440 | DEUTIVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
441 | Dexamethasone | 1件: Bortezomib Bortezomib | 1件: D03150
D03150
| 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
442 | Dexamethasone sodium phosphate 250 mg/10 ml solution | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
443 | DHA | 1件: Doconexent Doconexent | - | - | - | 8件: 6 6, 46, 48, 49, 94, 113, 299, 301 |
444 | Diagnostic Test: Candy Glucose Tolerance Test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
445 | Diagnostic Test: Continuous glucose monitoring | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
446 | Diagnostic Test: Dexa scan | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
447 | Diagnostic Test: Infant PFT | 1件: Bentiromide Bentiromide | 1件: D01346
D01346
| - | - | 1件: 299 299 |
448 | Diagnostic Test: Injected abdominal CT | - | - | - | - | 1件: 299 299 |
449 | Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine | 1件: Pilocarpine Pilocarpine | 3件: D00525
D00525
,
D02200
,
D05478
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
450 | Diagnostic Test: Lung Clearance Index | 1件: Bentiromide Bentiromide | 1件: D01346
D01346
| - | - | 1件: 299 299 |
451 | Diagnostic Test: Measurement of Sweat Chloride and Sweat Bromide | 1件: Chloride ion Chloride ion | - | - | - | 1件: 299 299 |
452 | Diagnostic Test: Nasal brushing | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
453 | Diagnostic Test: Oral glucose tolerance test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 3件: 13 13, 65, 299 |
454 | Diagnostic Test: Passive tidal breathing | 1件: Bentiromide Bentiromide | 1件: D01346
D01346
| - | - | 1件: 299 299 |
455 | Diagnostic Test: Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
456 | DICLOXACILLIN | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
457 | Diet | - | - | - | - | 3件: 97 97, 240, 299 |
458 | Digitoxin | 1件: Digitoxin Digitoxin | 1件: D00297
D00297
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
459 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
460 | Docosahexaenoic Acid (DHA) | 1件: Doconexent Doconexent | - | - | - | 3件: 6 6, 94, 299 |
461 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
462 | Docosahexanoic Acid Supplement | - | - | - | - | 1件: 299 299 |
463 | Dopamina | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
464 | DORIBAX | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
465 | Doripenem | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
466 | DORIPENEM HYDRATE | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
467 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 2件: 53 53, 299 |
468 | Dornase alfa (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
469 | Dornase alfa [Pulmozyme®] | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
470 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
471 | Doxycyclin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 2件: 97 97, 299 |
472 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
473 | DP Mannitol | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
474 | Dry powder tobramycin | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
475 | DTPA | 1件: Indium Indium | - | - | - | 2件: 28 28, 299 |
476 | Dual Energy X-ray Absorptiometry (DEXA) | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 299 299 |
477 | Dulaglutide | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
478 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
479 | DURAMYCIN | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
480 | Duramycin, 2622U90 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
481 | DX-890 | - | - | - | - | 1件: 299 299 |
482 | Ebselen | 1件: Ebselen Ebselen | - | - | - | 1件: 299 299 |
483 | ECGC | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 299 299 |
484 | EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
485 | EGCG + Tocotrienol | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 299 299 |
486 | Elasomeran | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
487 | ELEXACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
488 | Elexacaftor-tezacaftor-ivacaftor exposure | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
489 | Elexacaftor/tezacaftor/ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
490 | ELX | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
491 | ELX (VX-445)/TEZ (VX-661)/IVA (VX-770) | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
492 | ELX-02 | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 2件: 19 19, 299 |
493 | ELX/TEZ/IVA | - | - | - | - | 1件: 299 299 |
494 | EMEA/H/C/000125 | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 299 299 |
495 | Engineerd Protein Inhibitor of human Neutrophil Elastase | - | - | - | - | 1件: 299 299 |
496 | Engineered Protein Inhibitor of human Neutrophil Elastase | - | - | - | - | 1件: 299 299 |
497 | Ensure High Protein | - | - | - | - | 1件: 299 299 |
498 | Ensure plus | - | - | - | - | 1件: 299 299 |
499 | EPI-hNE4 DX-890 | - | - | - | - | 1件: 299 299 |
500 | Ergocalciferol | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 46 46, 84, 96, 97, 299 |
501 | Ergocalciferol (vitamin D2) | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
502 | Esomeprazole | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
503 | Essential amino acid intake + Leucine vs total AA supplement | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 1件: 299 299 |
504 | Estradiol | 1件: Estradiol Estradiol | 8件: D00105
D00105
,
D01413
,
D01617
,
D01953
,
D04061
,
D04063
,
D04064
,
D04065
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
505 | Estradiol 2 mg | 1件: Estradiol Estradiol | 8件: D00105
D00105
,
D01413
,
D01617
,
D01953
,
D04061
,
D04063
,
D04064
,
D04065
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 |
506 | ETD001 multiple once daily doses | - | - | - | - | 1件: 299 299 |
507 | ETD001 multiple twice daily doses | - | - | - | - | 1件: 299 299 |
508 | ETD001 single dose | - | - | - | - | 1件: 299 299 |
509 | Ethambutol | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 2件: 84 84, 299 |
510 | Ethinyl estradiol | 1件: Norethisterone Norethisterone | 2件: D00182
D00182
,
D00953
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 3件: 46 46, 49, 299 |
511 | EU Orphan Designation Number EU/3/02/120 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
512 | EUR-1008 | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
513 | EUR-1008 (APT-1008) | - | - | - | - | 1件: 299 299 |
514 | EUR-1008 25,000 Units | - | - | - | - | 1件: 299 299 |
515 | Exercise | - | - | - | - | 1件: 299 299 |
516 | Exhaled Nitric Oxide | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 1件: 299 299 |
517 | EZ-2053 | - | - | - | - | 2件: 85 85, 299 |
518 | EZ-2053 5mg/kg | - | - | - | - | 2件: 85 85, 299 |
519 | F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid) | - | - | - | - | 1件: 299 299 |
520 | Fasenra | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
521 | FDG-PET | 1件: Dimercaprol Dimercaprol | 1件: D00167
D00167
| - | - | 1件: 299 299 |
522 | FDL169 | - | - | - | - | 1件: 299 299 |
523 | FDL176 | - | - | - | - | 1件: 299 299 |
524 | FDL176 & FDL169 coadministration | - | - | - | - | 1件: 299 299 |
525 | Fenretinide | 1件: Fenretinide Fenretinide | 1件: D04162
D04162
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 |
526 | Ferinject | 1件: Iron Dextran Iron Dextran | 1件: D02141
D02141
| - | - | 2件: 86 86, 299 |
527 | FERRIC CARBOXYMALTOSE | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: D08920
D08920
| - | - | 4件: 86 86, 96, 97, 299 |
528 | Ferrous sulfate 325mg | 1件: Sulfate ion Sulfate ion | - | - | - | 1件: 299 299 |
529 | Finely ground flaxseed powder | 1件: Flax seed Flax seed | - | - | - | 1件: 299 299 |
530 | Fish Oil | 1件: Olive oil Olive oil | 1件: D03311
D03311
| - | - | 7件: 13 13, 46, 49, 66, 96, 260, 299 |
531 | Flaxseed | 1件: Flax seed Flax seed | - | - | - | 2件: 97 97, 299 |
532 | FLUCLOXACILLIN | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
533 | Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
534 | FLUCLOXACILLIN SODIUM | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
535 | Flucloxicillin | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
536 | FluMist | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
537 | Flumist® | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
538 | Fluticasone | 1件: Fluticasone Fluticasone | 1件: D07981
D07981
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
539 | FORLAX 4 g, poudre pour solution buvable en sachet | - | - | - | - | 1件: 299 299 |
540 | Formoterol | 1件: Formoterol Formoterol | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
541 | Fortum | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
542 | Frequently Sampled Oral Glucose Tolerance Test and CGM | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
543 | FTI, AZLI | - | - | - | - | 1件: 299 299 |
544 | Fucidin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
545 | Fucidin Tablets | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
546 | FUSIDIC ACID | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
547 | Fusidin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
548 | G1117337 | - | - | - | - | 2件: 67 67, 299 |
549 | G914167 | - | - | - | - | 1件: 299 299 |
550 | G957389 | - | - | - | - | 1件: 299 299 |
551 | GALICAFTOR | 1件: Galicaftor Galicaftor | 1件: D11724
D11724
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
552 | Gallium nitrate | 1件: Gallium nitrate Gallium nitrate | 1件: D00940
D00940
| - | - | 1件: 299 299 |
553 | Garlic | 1件: Garlic Garlic | 1件: D12020
D12020
| - | - | 1件: 299 299 |
554 | Genetic: Blood or Saliva Sample Collection | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 299 299 |
555 | GENISTEIN | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 2件: 19 19, 299 |
556 | Genistein (Unconjugated Isoflavones 100) | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
557 | Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
558 | Gentamicin | 1件: Gentamicin Gentamicin | 2件: D01063
D01063
,
D08013
| - | - | 3件: 36 36, 113, 299 |
559 | Gernebcin | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
560 | Gernebcin 80 mg | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
561 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 |
562 | GIP | - | - | - | - | 1件: 299 299 |
563 | Giving DHA-rich supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
564 | Glargine | - | - | - | - | 1件: 299 299 |
565 | Glargine insulin | - | - | - | - | 1件: 299 299 |
566 | GLP-1 | - | - | - | - | 1件: 299 299 |
567 | GLPG1837 | - | - | - | - | 1件: 299 299 |
568 | GLPG1837 dose 1 | - | - | - | - | 1件: 299 299 |
569 | GLPG1837 dose 2 | - | - | - | - | 1件: 299 299 |
570 | GLPG1837 dose 3 | - | - | - | - | 1件: 299 299 |
571 | GLPG2222 | - | - | - | - | 1件: 299 299 |
572 | GLPG2222 100 mg | - | - | - | - | 1件: 299 299 |
573 | GLPG2222 150 mg q.d. | - | - | - | - | 1件: 299 299 |
574 | GLPG2222 200 mg | - | - | - | - | 1件: 299 299 |
575 | GLPG2222 300 mg q.d. | - | - | - | - | 1件: 299 299 |
576 | GLPG2222 400 mg | - | - | - | - | 1件: 299 299 |
577 | GLPG2222 50 mg | - | - | - | - | 1件: 299 299 |
578 | GLPG2451 dose regimen A | - | - | - | - | 1件: 299 299 |
579 | GLPG2451 dose regimen B | - | - | - | - | 1件: 299 299 |
580 | GLPG2737 | - | - | - | - | 2件: 67 67, 299 |
581 | GLPG2737 single dose | - | - | - | - | 1件: 299 299 |
582 | GLPG3067 | - | - | - | - | 1件: 299 299 |
583 | GLPG3067 single dose | - | - | - | - | 1件: 299 299 |
584 | Glucose | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 15件: 2 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 |
585 | Glutamine | 1件: L-Glutamine L-Glutamine | 1件: D00015
D00015
| - | - | 7件: 87 87, 89, 96, 97, 113, 245, 299 |
586 | Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
587 | GLUTATHIONE SODIUM | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
588 | GLYCINE | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 5件: 35 35, 60, 86, 226, 299 |
589 | Glycine Buffer | 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 1件: 299 299 |
590 | GlycosBio Nutritional Supplement | - | - | - | - | 1件: 299 299 |
591 | GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.) | 1件: Tranexamic acid Tranexamic acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 299 299 |
592 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
593 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 13件: 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299 |
594 | Growth Hormone Stimulation Test | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 299 299 |
595 | GS-5737 | - | - | - | - | 1件: 299 299 |
596 | GS-5745 | 1件: GS-5745 GS-5745 | - | - | - | 4件: 46 46, 96, 97, 299 |
597 | GS-9411 | - | - | - | - | 1件: 299 299 |
598 | GSH | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
599 | GSH (Glutathione) | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
600 | H02 - Corticosteroidi Sistemici | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
601 | Helium | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 3件: 228 228, 299, 330 |
602 | Helium-3 | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 2件: 228 228, 299 |
603 | Heparin | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 12件: 47 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 |
604 | Heparin 25mg inhalation powder, hard capsule | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 299 299 |
605 | Heparin Sodium | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 280 280, 299 |
606 | Heracillin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
607 | HFNT during exercise | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
608 | HGPIV diagnosis test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
609 | High dose of budesonide | 1件: Formoterol Formoterol | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
610 | High flow nasal oxygen cannula | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
611 | High-Dose Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
612 | History and physical exam. | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 231 231, 299 |
613 | HMSCs | - | - | - | - | 1件: 299 299 |
614 | HOMAR-IR diagnosis test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
615 | Home Oral Glucose Tolerance Test kit | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
616 | Honey | 1件: Honey Honey | 1件: D06776
D06776
| - | - | 3件: 57 57, 98, 299 |
617 | HP 129Xe | - | - | - | - | 1件: 299 299 |
618 | HP 3He | - | - | - | - | 1件: 299 299 |
619 | Human recombinant growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 13 13, 299 |
620 | Hyaluronan | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 1件: 299 299 |
621 | Hydrocortisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
622 | Hydroxychloroquine | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
623 | Hyperglycemic clamp | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
624 | Hyperglycemic Clamp with concurrent GIP infusion | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
625 | Hyperglycemic clamp with concurrent GLP-1 infusion | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
626 | Hyperpolarized Helium-3 | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 1件: 299 299 |
627 | Hyperpolarized Helium-3 MRI of the chest | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 1件: 299 299 |
628 | Hyperpolarized Xe129 | - | - | - | - | 2件: 85 85, 299 |
629 | Hyperpolarized Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
630 | Hyperpolarized Xenon 129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
631 | Hyperpolarized Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
632 | Hyperpolarized xenon-129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
633 | Hypertonic bicarbonate | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
634 | HYPERTONIC SALINE | - | - | - | - | 1件: 299 299 |
635 | Hypertonic saline (7 %) and isotonic saline (0.9%) | - | - | - | - | 1件: 299 299 |
636 | Hypertonic saline (7%) | - | - | - | - | 1件: 299 299 |
637 | Hypertonic saline 6% - | - | - | - | - | 1件: 299 299 |
638 | Hypertonic Saline 7% | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
639 | Hypertonic saline solution | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
640 | Ibuprofen | 1件: Ibuprofen Ibuprofen | 4件: D00126
D00126
,
D01122
,
D04490
,
D06606
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 7件: 13 13, 46, 65, 107, 113, 271, 299 |
641 | Icenticaftor | - | - | - | - | 1件: 299 299 |
642 | ICS+LABA | - | - | - | - | 1件: 299 299 |
643 | IDPM | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
644 | IDPM: Inhaled Dry Powder Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
645 | IGE025 | 1件: Omalizumab Omalizumab | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 299 299 |
646 | IgY | - | - | - | - | 1件: 299 299 |
647 | Impact | 1件: Topramezone Topramezone | - | - | - | 8件: 6 6, 13, 46, 50, 53, 96, 97, 299 |
648 | Impact-Nutridrink | 1件: Topramezone Topramezone | - | - | - | 1件: 299 299 |
649 | Increlex | 1件: Mecasermin Mecasermin | 2件: D03297
D03297
,
D04870
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 4件: 65 65, 78, 96, 299 |
650 | INCRELEX*SC 1FL 4ML 10MG/ML | 1件: Mecasermin Mecasermin | 2件: D03297
D03297
,
D04870
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 299 299 |
651 | Indirect Calorimetry | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 299 299 |
652 | Indium | 1件: Indium Indium | - | - | - | 3件: 28 28, 84, 299 |
653 | Indium-DTPA | 1件: Gelatin Gelatin | 2件: D00115
D00115
,
D06892
| - | - | 1件: 299 299 |
654 | INDUSIL*OS GTT FL 30MG+FL 15ML | 1件: Cobamamide Cobamamide | 1件: D00042
D00042
| - | - | 1件: 299 299 |
655 | Influenza vaccination | - | - | - | - | 1件: 299 299 |
656 | Inhaled 7% hypertonic saline (HS) | - | - | - | - | 1件: 299 299 |
657 | Inhaled AR-501 | - | - | - | - | 1件: 299 299 |
658 | Inhaled Dry Powder Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
659 | Inhaled hypertonic saline (7%) | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
660 | Inhaled Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
661 | Inhaled Reduced Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
662 | Inhaled SNSP113 | - | - | - | - | 1件: 299 299 |
663 | Inhaled Sodium Pyruvate | - | - | - | - | 1件: 299 299 |
664 | Inhaled tobramycin | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
665 | Inhaled Vancomycin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
666 | Initiation of CFTR Modulator | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
667 | INOmax | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 3件: 85 85, 294, 299 |
668 | INOmax 400ppm mol/mol inhalation gas | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 85 85, 299 |
669 | INS1007 | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 2件: 44 44, 299 |
670 | INS1007 10 mg oral tablet | - | - | - | - | 1件: 299 299 |
671 | INS1007 25 mg oral tablet | - | - | - | - | 1件: 299 299 |
672 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 78, 299 |
673 | Insulin Asparte | 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 299 299 |
674 | Insulin detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
675 | Insulin detemir [rDNA origin] injection | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
676 | Insulin glargine | 1件: Insulin glargine Insulin glargine | 1件: D03250
D03250
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, |